IDC TechScape:全球生命科學臨床試驗技術 (2015年)
IDC TechScape: Worldwide Life Science Clinical Trials Technologies, 2015
|出版日期||內容資訊||英文 23 Pages
|IDC TechScape:全球生命科學臨床試驗技術 (2015年) IDC TechScape: Worldwide Life Science Clinical Trials Technologies, 2015|
|出版日期: 2015年02月23日||內容資訊: 英文 23 Pages||
This IDC study uses the IDC TechScape model to provide an assessment of both industry-specific and industry-agnostic technology adoption supporting the worldwide life science clinical trials market. The IDC TechScape is an evaluation model based on a comprehensive framework and a set of parameters that assess a technology's adoption progress relative to one another and to those factors expected to be most conducive to success in a given market over both the short- and the long term. In breaking technologies into three major adoption categories, transformational, incremental, and opportunistic, the IDC TechScape aspires to provide IT buyers with an industry snapshot as to where specific technologies lie today relative to current industry best practices. In addition, the IDC TechScape identifies technologies likely to become best practices in the future and their current state of adoption maturity relative to each other. Within our discussions of individual technologies, we also identify our analyst's best opinions regarding key momentum factors, highlighted as IDC TechScape Spotlights, where we rate technologies based on adoption speed, risk, and market interest.
"Modernizing the clinical trial process requires a confluence of relevant technologies. With this study, we provide our clients with a way to categorize those technologies and construct an optimal investment strategy." - Alan Louie, research director, Clinical Development, Strategy and Technology